unknown
Stage
1
Investors
About
Abionic is a Swiss medical diagnostics company that develops nanotechnology-based point-of-care immunoassay systems (notably the abioSCOPE) and related rapid in vitro diagnostic tests.
Explore Abionic's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.